Arbutus Biopharma Corp Annual Net Cash Provided by (Used in) Financing Activities in USD from 2011 to 2023

Taxonomy & unit
us-gaap: CAD and USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Arbutus Biopharma Corp quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2011 to 2023.
  • Arbutus Biopharma Corp Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $24.4M, a 19.7% increase year-over-year.
  • Arbutus Biopharma Corp annual Net Cash Provided by (Used in) Financing Activities for 2023 was $30.6M, a 3.67% decline from 2022.
  • Arbutus Biopharma Corp annual Net Cash Provided by (Used in) Financing Activities for 2022 was $31.8M, a 76.8% decline from 2021.
  • Arbutus Biopharma Corp annual Net Cash Provided by (Used in) Financing Activities for 2021 was $137M, a 58.2% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Trailing 12 Months (USD)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $30.6M -$1.17M -3.67% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-05
2022 $31.8M -$105M -76.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-05
2021 $137M +$50.5M +58.2% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-02
2020 $86.7M +$49.3M +132% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-03
2019 $37.5M -$18.2M -32.7% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-04
2018 $55.6M +$6.32M +12.8% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-05
2017 $49.3M +$36.7M +290% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-07
2016 $12.6M -$131M -91.2% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-16
2015 $144M +$83.2M +137% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-16
2014 $60.7M +$28M +85.5% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-22
2013 $32.7M +$28.2M +620% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-09
2012 $4.55M -$62.6K -1.36% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-13
2011 $4.61M Jan 1, 2011 Dec 31, 2011 10-K 2014-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.